NDC 64678-211
BioThrax
Bacillus Anthracis
BioThrax is a Intramuscular; Subcutaneous Injection, Suspension in the Vaccine category. It is labeled and distributed by Emergent Biodefense Operations Lansing, Llc. The primary component is Bacillus Anthracis Strain V770-np1-r Antigens.
| Product ID | 64678-211_12832647-b320-4bb4-8697-6679c2613030 |
| NDC | 64678-211 |
| Product Type | Vaccine |
| Proprietary Name | BioThrax |
| Generic Name | Bacillus Anthracis |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRAMUSCULAR; SUBCUTANEOUS |
| Marketing Start Date | 1970-11-04 |
| Marketing Category | BLA / BLA |
| Application Number | BLA103821 |
| Labeler Name | Emergent BioDefense Operations Lansing, LLC |
| Substance Name | BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS |
| Active Ingredient Strength | 100 ug/mL |
| Pharm Classes | Live Attenuated Bacillus Anthracis Vaccine [EPC],Actively Acquired Immunity [PE],Vaccines, Attenuated [Chemical/Ingredient],Anthrax Vaccines [Chemical/Ingredient] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
Packaging
NDC 64678-211-01
1 VIAL, MULTI-DOSE in 1 CARTON (64678-211-01) > 5 mL in 1 VIAL, MULTI-DOSE (64678-211-05)
| Marketing Start Date | 1970-11-04 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 64678-211-01 [64678021101]
BioThrax INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA103821 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 2013-01-31 |
NDC 64678-211-05 [64678021105]
BioThrax INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA103821 |
| Product Type | VACCINE |
| Billing Unit | ML |
| Marketing Start Date | 1970-11-04 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS | 100 ug/mL |
Pharmacological Class
- Live Attenuated Bacillus Anthracis Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Vaccines
- Attenuated [Chemical/Ingredient]
- Anthrax Vaccines [Chemical/Ingredient]
- Live Attenuated Bacillus Anthracis Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Vaccines
- Attenuated [Chemical/Ingredient]
- Anthrax Vaccines [Chemical/Ingredient]
Trademark Results [BioThrax]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BIOTHRAX 76541650 2928540 Live/Registered |
EMERGENT BIODEFENSE OPERATIONS LANSING LLC 2003-08-25 |
 BIOTHRAX 75673278 not registered Dead/Abandoned |
BIOPORT CORPORATION 1999-04-02 |
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.